AMGEN Inc

AMGNNASDAQ · USD
457.93USD0.00 (-0.95%)
6910

AMGEN Inc (AMGN) Expected Move

AMGN expected move through Nov 20, 2026 is 2.7%, with 2 days to expiration. The implied range is $445.44 to $470.42, based on the previous trading day's options prices.

Read more

Tracking the AMGN expected move helps you see how far AMGEN Inc's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. AMGEN Inc's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the AMGN expected move for this week's options, in real time.

The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For AMGN, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The AMGN expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks AMGEN Inc is unlikely to go.

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization.

Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the AMGN expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The AMGEN Inc expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about AMGN.

AMGN Price

EARN
EM

Drag chart to pan. Drag axes to zoom.

ExpirationDTEExpected move (USD)Expected move (%)Upper priceLower price
Nov 20, 20262$12.492.7%$470.42$445.44
Nov 27, 20269$19.084.2%$477.01$438.86
Dec 4, 202616$23.695.2%$481.62$434.24
Dec 11, 202623$28.456.2%$486.38$429.48

As of Nov 17, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →